Search results
Showing 181 to 195 of 600 results for diabetes
treatment in people with type 1 diabetes? Any explanatory notes(if applicable) People with type 1 diabetes have increased...
Vitamin D: supplement use in specific population groups (PH56)
This guideline covers vitamin D supplement use. It aims to prevent vitamin D deficiency among specific population groups including infants and children aged under 4, pregnant and breastfeeding women, particularly teenagers and young women, people over 65, people who have low or no exposure to the sun and people with dark skin.
Summary of the evidence on oral erythromycin for gastroparesis (delayed stomach emptying) in adults to inform local NHS planning and decision-making
NICE has developed a medtech innovation briefing (MIB) on FreeStyle Libre for glucose monitoring .
peripheral arterial disease in people with diabetes? Any explanatory notes(if applicable) People with diabetes are at...
LY3209590 for treating type 2 diabetes in people on daily insulin injections [ID6499]
Awaiting development [GID-TA11644] Expected publication date: TBC
In development [GID-TA11352] Expected publication date: TBC
Diabetes: blood pressure (without moderate or severe frailty)
This indicator has been updated and replaced by NICE indicator 249.
Cardiovascular disease. Patient decision aid on should I take a statin?
damage. 5 Diabetes If you do not have type 2 diabetes, taking a statin increases your chance of getting it. But statins do...
with diabetes to achieve blood glucose targets before pregnancy? Any explanatory notes(if applicable) Babies born to women with...
Evidence-based recommendations on glycoprotein IIb/IIIa inhibitors (abciximab, eptifibatide, tirofiban) for treating acute coronary syndromes in adults.
Healthy.io test for home testing of urine albumin to creatinine ratio (MIB221)
NICE has developed a medtech innovation briefing (MIB) on Healthy.io test for home testing of urine albumin to creatinine ratio .
optimal frequency for self‑monitoring of blood glucose in adults with type 2 diabetes? Any explanatory notes(if applicable) Why this is...
Evidence-based recommendations on dapagliflozin (Forxiga) for treating chronic heart failure with preserved or mildly reduced ejection fraction in adults.
This indicator covers the percentage of patients with moderate or severe frailty and/or multimorbidity who have received a medication review in the last 12 months which is structured, has considered the use of a recognised tool and taken place as a shared discussion. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM186